We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
AMG 181 Phase 2 Study in Subjects With Moderate to Severe Ulcerative Colitis
Updated: 11/17/2017
A Randomized, Double Blind, Multiple Dose Placebo Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 181 in Subjects With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 11/17/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Updated: 11/19/2017
A Phase ll, Randomized, Double-blind, Placebo-controlled Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis.
Status: Enrolling
Updated: 11/19/2017
Click here to add this to my saved trials
Biomarkers in Phototherapy of Barrett's Esophagus
Updated: 11/20/2017
Biomarkers in Phototherapy of Barrett's Esophagus
Status: Enrolling
Updated: 11/20/2017
Biomarkers in Phototherapy of Barrett's Esophagus
Updated: 11/20/2017
Biomarkers in Phototherapy of Barrett's Esophagus
Status: Enrolling
Updated: 11/20/2017
Click here to add this to my saved trials
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Updated: 11/21/2017
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Status: Enrolling
Updated: 11/21/2017
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Updated: 11/21/2017
An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis Patients
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Updated: 11/21/2017
CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/21/2017
Click here to add this to my saved trials